Silence Therapeutics plc (SLN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:45PM EDT. Market open.
| Previous close | 21.99 |
| Open | 22.09 |
| Bid | 22.29 x 100 |
| Ask | 22.50 x 100 |
| Day's range | 22.06 - 22.67 |
| 52-week range | 4.84 - 27.72 |
| Volume | |
| Avg. volume | 229,355 |
| Market cap | 1.136B |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
- Simply Wall St.
Analysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Results
It's shaping up to be a tough period for Silence Therapeutics plc ( NASDAQ:SLN ), which a week ago released some...
- Insider Monkey
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript March 13, 2024 Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25. SLN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
© 2024 Yahoo. All rights reserved.